BiotechTubeBiotechTube
Intima Bioscience

Intima Bioscience

Phase 1
London, United KingdomFounded 2019intimabioscience.com

Dr. Emil Lou, Intima Bioscience Principal Investigator, Named to 2026 TIME100 Health List Read Press Release Contact A clinical-stage company focused on a next-generation small molecule checkpoint inhibitor CISH IMMUNE CHECKPOINT TARGET THE NEXT GENERATION OF CANCER PLATFORM TECHNOLOGY CISH: a novel immune checkpoint Small molecule checkpoint inhibitor DRUGGING THE UNDRUGGABLE INTIMA BIOSCIENCE CLINICAL TRIAL […]

Founded
2019
Focus
Cell & Gene Therapy

About

Dr. Emil Lou, Intima Bioscience Principal Investigator, Named to 2026 TIME100 Health List Read Press Release Contact A clinical-stage company focused on a next-generation small molecule checkpoint inhibitor CISH IMMUNE CHECKPOINT TARGET THE NEXT GENERATION OF CANCER PLATFORM TECHNOLOGY CISH: a novel immune checkpoint Small molecule checkpoint inhibitor DRUGGING THE UNDRUGGABLE INTIMA BIOSCIENCE CLINICAL TRIAL […]

Company Info

TypePrivate
Founded2019
LocationLondon, United Kingdom
StagePhase 1

Contact

intimabioscience.com

Sectors

Small Molecule DrugsImmunotherapy / Immuno-Oncology
SIMILAR COMPANIES
Abbexa
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Accentus Medical
Pre-clinical · Oxford
AbOliGo
AbOliGo
Pre-clinical · London
Bigespas
Bigespas
Pre-clinical · London
Actimed Therapeutics
Actimed Therapeutics
Pre-clinical · London
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile